12 Days of RA Christmas

RA Guy Community News 22 Comments

Vicki Corson said:

12days_lgAlright folks, I think its time to start the 12 Arthritic Days of Christmas…add the next line:
On the first day of Christmas Arthritis gave to me a cortisone shot in my knee….

Reumapatientenbond: In Motion

RA Guy Community News Leave a Comment

In BewegingFellow superhero Ferhaan – from the Netherlands – was recently interviewed for the monthly publication of the Dutch Arthritis Foundation: “In Beweging” (“In Motion”). Starting this January, Ferhaan will be contributing a monthly column for this magazine.

Please join me in wishing Ferhaan the best as he embarks on this new endeavor!

In the meantime, you can visit him at Ferhaan’s Blog.

For more information on the Dutch Arthritis Foundation, please visit: http://www.reumabond.nl/.

If you are in the area, be sure to take a look at this December issue…I am told that Rheumatoid Arthritis Guy is mentioned as well!

Living It, Loving It: Having Rheumatoid Arthritis And Being A Mother

RA Guy Community News Leave a Comment

Raising Children in this day and age is tough enough, but add chronic illness to the mix, and you have a whole of emotional and physical challenges to deal with in addition to what you already have to do.

Read More: http://ohboy-boys.blogspot.com/2009/12/having-rheumatoid-arthritis-and-being.html

Cathy from The Life and Adventures of Cateepoo also wrote a guest post on Parenting & RA, for anyone who is looking for more information on this topic.

Biologics Legislation

RA Guy Community News 3 Comments

Eshoo bill huge boon for Silicon Valley biotech

Buried in the giant health care bills in Congress is a multibillion-dollar bonanza for Silicon Valley’s biotechnology and venture capital industries, sponsored by Rep. Anna Eshoo, a Palo Alto Democrat.

The provision would grant “biologic” drugs, a new class of drugs based on gene splicing and grown in living cells, 12 years of protection from competition by the generic drug industry, in addition to their patents.

A scathing report by the Federal Trade Commission in June said no added protection, much less 12 years, was warranted, and warned that the Eshoo legislation would ensure sky-high drug prices and stifle innovation on the most promising frontier of medical research.

Read More: http://www.sfgate.com/cgi-bin/article.cgi?file=/c/a/2009/12/06/MNFQ1AV2C3.DTL